Delineation of Supraclavicular Target Volumes in Breast Cancer Radiation Therapy. In Reply to Yang and Guo.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Optimization of supraclavicular lymph node clinical target volume delineation in high-risk breast cancer: a single center experience and recommendation.BMC cancer · 2023
   Article
2. Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee.International journal of radiation oncology, biology, physics · 2021
   Review
3. Patterns of supraclavicular area failure after mastectomy in breast cancer patients: implications for target volume delineation.The Journal of international medical research · 2020
   Article

Corrections and comments

• Comment on
  Delineation of Supraclavicular Target Volumes in Breast Cancer Radiation Therapy.2015
• Comment on
  Delineation of Supraclavicular Target Volumes in Breast Cancer Radiation Therapy. In Regard to Brown et al.2015

Authors and funding

8 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as